Qiang Zhao
Direttore/Membro del Consiglio presso Shanghai Haihe Biopharma Co., Ltd.
Posizioni attive di Qiang Zhao
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Shanghai Haihe Biopharma Co., Ltd.
 Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Direttore/Membro del Consiglio | 08/09/2020 | - |
| Independent Dir/Board Member | 08/09/2020 | - |
Storia della carriera di Qiang Zhao
Precedenti posizioni note di Qiang Zhao
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BEIJING CHIEFTAIN CONTROL ENGINEERING TECHNOLOGY CO., LTD. | Direttore/Membro del Consiglio | 26/05/2017 | 10/06/2023 |
| Independent Dir/Board Member | 26/05/2017 | 10/06/2023 | |
| JOINTO ENERGY INVESTMENT CO., LTD. HEBEI | Direttore/Membro del Consiglio | 12/09/2014 | - |
| Independent Dir/Board Member | 12/09/2014 | - |
Statistiche
Distribuzione geografica
| Cina | 4 |
Posizioni
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
Settori
| Utilities | 2 |
| Producer Manufacturing | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| JOINTO ENERGY INVESTMENT CO., LTD. HEBEI | Utilities |
| BEIJING CHIEFTAIN CONTROL ENGINEERING TECHNOLOGY CO., LTD. | Producer Manufacturing |
| Aziende private | 1 |
|---|---|
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |
- Borsa valori
- Insiders
- Qiang Zhao
- Esperienza
